Effects of Rich in Β-Glucans Edible Mushrooms on Aging Gut Microbiota Characteristics: An In Vitro Study Show others and affiliations
2020 (English) In: Molecules, ISSN 1431-5157, E-ISSN 1420-3049, Vol. 25, no 12, article id 2806Article in journal (Refereed) Published
Abstract [en]
Alterations of gut microbiota are evident during the aging process. Prebiotics may restore the gut microbial balance, with β-glucans emerging as prebiotic candidates. This study aimed to investigate the impact of edible mushrooms rich in β-glucans on the gut microbiota composition and metabolites by using in vitro static batch culture fermentations and fecal inocula from elderly donors (n = 8). Pleurotus ostreatus, P. eryngii, Hericium erinaceus and Cyclocybe cylindracea mushrooms derived from various substrates were examined. Gut microbiota composition (quantitative PCR (qPCR)) and short-chain fatty acids (SCFAs; gas chromatography (GC)) were determined during the 24-h fermentation. P. eryngii induced a strong lactogenic effect, while P. ostreatus and C. cylindracea induced a significant bifidogenic effect (p for all <0.05). Furthermore, P. eryngii produced on wheat straw and the prebiotic inulin had comparable Prebiotic Indexes, while P. eryngii produced on wheat straw/grape marc significantly increased the levels of tested butyrate producers. P. ostreatus, P. eryngii and C. cylindracea had similar trends in SCFA profile; H. erinaceus mushrooms were more diverse, especially in the production of propionate, butyrate and branched SCFAs. In conclusion, mushrooms rich in β-glucans may exert beneficial in vitro effects in gut microbiota and/or SCFAs production in elderly subjects.
Place, publisher, year, edition, pages MDPI, 2020. Vol. 25, no 12, article id 2806
Keywords [en]
Cyclocybe cylindracea, Hericium erinaceus, Pleurotus eryngii, Pleurotus ostreatus, SCFAs, aging, edible mushroom, gut microbiota, prebiotics, β-glucans
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers URN: urn:nbn:se:oru:diva-110916 DOI: 10.3390/molecules25122806 ISI: 000550254100001 PubMedID: 32570735 Scopus ID: 2-s2.0-85086943755 OAI: oai:DiVA.org:oru-110916 DiVA, id: diva2:1829806
Note This research was co-funded by the EU and Greek national funds, through the Operational Program Competitiveness, Entrepreneurship and Innovation under the call RESEARCH-CREATE-INNOVATE (T1EDK-03404).
2024-01-202024-01-202024-03-05 Bibliographically approved